BAFNAPH — Bafna Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.90bn
- IN₹2.08bn
- IN₹1.53bn
- 29
- 27
- 50
- 24
Annual cashflow statement for Bafna Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
C2020 March 31st | 2021 March 31st | C2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -18.8 | 58.3 | 51.9 | 118 | 73.5 |
| Depreciation | |||||
| Non-Cash Items | -235 | -6.61 | 15.7 | 16.2 | 30.3 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -122 | -233 | -25.3 | -138 | -58.9 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -343 | -136 | 97.3 | 49.5 | 94.8 |
| Capital Expenditures | -14.3 | -60.9 | -75.4 | -82.2 | -158 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 342 | 7.49 | 9.97 | 7.26 | 7.95 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 328 | -53.5 | -65.4 | -74.9 | -151 |
| Financing Cash Flow Items | -48.4 | -0.886 | -0.882 | -16.9 | -23.1 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 72.7 | 123 | -48.1 | 102 | -8.45 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 57.8 | -66.8 | -16.3 | 76.4 | -64.1 |